Inivata

company

About

Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis.

  • 51 - 100

Details

Last Funding Type
Corporate Round
Last Funding Money Raised
$25M
Industries
Biotechnology,Genetics,Health Care,Medical Device
Founded date
Jan 1, 2014
Number Of Employee
51 - 100
Operating Status
Active

Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients.

Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$77.60M £35.50M
Inivata has raised a total of $77.60M £35.50M in funding over 2 rounds. Their latest funding was raised on May 26, 2020 from a Corporate Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 26, 2020 Corporate Round $25M 1 NeoGenomics Detail
Mar 28, 2019 Series B $52.60M 1 Detail
Jan 26, 2016 Series A £31.50M 1 Detail
Sep 23, 2014 Series Unknown £4M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Inivata is funded by 2 investors. NeoGenomics and Cambridge Innovation Capital are the most recent investors.
Investor Name Lead Investor Funding Round
NeoGenomics Yes Corporate Round
Cambridge Innovation Capital Series B